ArticleChemical science2026
Control of axial stereochemistry for the enantioselective construction of a QUINAP library.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
QUINAP, a classic axially chiral P,N-ligand based on the skeleton of an atropisomeric heterobiaryl, has been widely applied in various types of enantioselective transformations. To date, the efficient construction of a QUINAP library with high enantioselectivity is still underdeveloped. Herein, we report a two-step synthesis of QUINAP derivatives from racemic QUINOLs with high enantioselectivity by controlling the dynamic axial stereochemistry in heterobiaryl skeletons. Under heating, solvent-dependent crystallization-induced deracemization (CID) of QUINOLs was realized with chiral ammonium salt. Subsequently, palladium-catalyzed stereospecific phosphination of enantioenriched QUINOLs delivered QUINAP products with high enantiopurity. The bidentate phosphine ligand dppp (1,3-bis(diphenylphosphino)propane) plays a key role in favoring the phosphination pathway over axial rotation. Density functional theory (DFT) calculations have provided clear insights into the palladium-catalyzed stereospecific phosphination pathway. Finally, construction of a QUINAP library was accomplished with excellent enantiopurity, and it was successfully applied in the A3-coupling and alkene hydroboration reactions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.